Economic inequalities in the effectiveness of a primary care intervention for depression and suicidal ideation

Epidemiology

Volumn 24, Issue 1, 2013, Pages 14-22

  Gilman, Stephen E ^a,b   Fitzmaurice, Garrett M ^a,c   Bruce, Martha L ^d   Have, Thomas Ten ^e   Glymour, M Maria ^a   Carliner, Hannah ^a   Alexopoulos, George S ^d   Mulsant, Benoit H ^f   Reynolds, Charles F ^g   Cohen, Alex ^h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; ECONOMIC ASPECT; ECONOMIC EVALUATION; EFFECT SIZE; FEMALE; FINANCIAL DEFICIT; HAMILTON SCALE; HEALTH CARE DISPARITY; HUMAN; INTERVENTION STUDY; LATE LIFE DEPRESSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; POVERTY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SUICIDAL IDEATION; SYMPTOM;

AGED; AGED, 80 AND OVER; DEPRESSION; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS DISPARITIES; HEALTHCARE DISPARITIES; HUMANS; LINEAR MODELS; LOGISTIC MODELS; MALE; MIDDLE AGED; POVERTY; POVERTY AREAS; PRIMARY HEALTH CARE; SUICIDAL IDEATION; SUICIDE; TREATMENT OUTCOME;

EID: 84871774870     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182762403     Document Type: Article

References (54)

1. Cohen A, Houck PR, Szanto K, Dew MA, Gilman SE, Reynolds CF 3rd. Social inequalities in response to antidepressant treatment in older adults. Arch Gen Psychiatry. 2006;63:50-56. (Pubitemid 43037468)
2. Friedman ES, Wisniewski SR, Gilmer W, et al. Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial. Depress Anxiety. 2009;26:612-621.
3. Gilman SE, Trinh NH, Smoller JW, Fava M, Murphy JM, Breslau J. Psychosocial stressors and the prognosis of major depression: a test of Axis IV [published online ahead of print 28 May 2012]. Psycol Med. doi: 10.1017/S0033291712001080.
4. Gilman SE, Carliner H, Cohen A. The social determinants of depression in older adulthood. In: Lavretsky H, Sajatovic M, Reynolds CF. Late-Life Mood Disorders. New York, NY: Oxford University Press. In press.
5. Gilman SE, Kawachi I, Fitzmaurice GM, Buka SL. Socioeconomic status in childhood and the lifetime risk of major depression. Int J Epidemiol. 2002;31:359-367. (Pubitemid 34537793)
6. Roy-Byrne PP, Joesch JM, Wang PS, Kessler RC. Low socioeconomic status and mental health care use among respondents with anxiety and depression in the NCS-R. Psychiatr Serv. 2009;60:1190-1197.
7. Harman JS, Edlund MJ, Fortney JC. Disparities in the adequacy of depression treatment in the United States. Psychiatr Serv. 2004;55:1379-1385. (Pubitemid 39577973)
8. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:629-640. (Pubitemid 40973438)
9. Houle J, Beaulieu MD, Lespérance F, Frasure-Smith N, Lambert J. Inequities in medical follow-up for depression: a population-based study in Montreal. Psychiatr Serv. 2010;61:258-263.
10. Stockdale SE, Lagomasino IT, Siddique J, McGuire T, Miranda J. Racial and ethnic disparities in detection and treatment of depression and anxiety among psychiatric and primary health care visits, 1995-2005. Med Care. 2008;46:668-677.
11. Harman JS, Veazie PJ, Lyness JM. Primary care physician office visits for depression by older Americans. J Gen Intern Med. 2006;21:926-930. (Pubitemid 44141760)
12. Stafford RS, Ausiello JC, Misra B, Saglam D. National patterns of depression treatment in primary care. Prim Care Companion J Clin Psychiatry. 2000;2:211-216.
13. Kessler RC, Berglund P, Demler O, et al. National Comorbidity Survey Replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095-3105. (Pubitemid 37432885)
14. Alexopoulos GS, Katz IR, Bruce ML, et al. PROSPECT Group. Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry. 2005;162:718-724. (Pubitemid 40489134)
15. Bogner HR, Cary MS, Bruce ML, et al. The role of medical comorbidity in outcome of major depression in primary care: the PROSPECT study. Am J Geriatr Psychiatry. 2005;13:861-868. (Pubitemid 46638674)
16. Bruce ML, Ten Have TR, Reynolds CF 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients: a randomized controlled trial. JAMA. 2004;291:1081-1091. (Pubitemid 38541685)
17. Alexopoulos GS, Reynolds CF 3rd, Bruce ML, et al. PROSPECT Group. Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry. 2009;166:882-890.
18. Gallo JJ, Bogner HR, Morales KH, Post EP, Lin JY, Bruce ML. The effect of a primary care practice-based depression intervention on mortality in older adults: a randomized trial. Ann Intern Med. 2007;146: 689-698.
19. Bruce ML, Pearson JL. Designing an intervention to prevent suicide: PROSPECT (Prevention of Suicide in Primary Care Elderly: Collaborative Trial). Dialogues Clin Neurosci. 1999;1:100-112.
20. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatr. 1960;23:56-62.
21. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry. 1991;48:851-855.
22. Beck AT, Brown GK, Steer RA. Psychometric characteristics of the Scale for Suicide Ideation with psychiatric outpatients. Behav Res Ther. 1997;35:1039-1046. (Pubitemid 27522426)
23. Gilman SE, Bruce ML, Have TT, et al. Social inequalities in depression and suicidal ideation among older primary care patients [published online ahead of print 5 September 2012]. Soc Psychiatry Psychiatr Epidemiol. doi: 10.1007/s00127-012-0575-9.
24. Bishaw A. United States Bureau of the Census. Areas with Concentrated Poverty, 1999: Census 2000 Special Reports. Censr. Washington, DC: U.S. Department of Commerce, Economics and Statistics Administration, U.S. Census Bureau; 2005.
25. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383. (Pubitemid 17055592)
26. Rothwell PM. Treating individuals 2. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365:176-186. (Pubitemid 40091809)
27. Kraemer HC, Frank E, Kupfer DJ. Moderators of treatment outcomes: clinical, research, and policy importance. JAMA. 2006;296:1286-1289. (Pubitemid 44394901)
28. Fitzmaurice GM, Laird NM, Ware JH. Applied Longitudinal Analysis Wiley Series in Probability and Statistics. Hoboken, NJ: Wiley-Interscience; 2004.
29. Kraemer HC, Wilson GT, Fairburn CG, Agras WS. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59:877-883.
30. Brookes ST, Whitely E, Egger M, Smith GD, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials: risks of subgroup-specific analyses; power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229-236. (Pubitemid 38456874)
31. Kahn JR, Pearlin LI. Financial strain over the life course and health among older adults. J Health Soc Behav. 2006;47:17-31. (Pubitemid 44237648)
32. Zimmerman FJ, Katon W. Socioeconomic status, depression disparities, and financial strain: what lies behind the income-depression relationship? Health Econ. 2005;14:1197-1215. (Pubitemid 43013603)
33. Paczkowski MM, Galea S. Sociodemographic characteristics of the neighborhood and depressive symptoms. Curr Opin Psychiatry. 2010;23:337-341.
34. VanderWeele TJ, Knol MJ. Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions. Ann Intern Med. 2011;154:680-683.
35. Cohen A, Chapman BP, Gilman SE, et al. Social inequalities in the occurrence of suicidal ideation among older primary care patients. Am J Geriatr Psychiatry. 2010;18:1146-1154.
36. Cohen A, Gilman SE, Houck PR, Szanto K, Reynolds CF 3rd. Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Soc Psychiatry Psychiatr Epidemiol. 2009;44:272-277.
37. Olfson M, Shea S, Feder A, et al. Prevalence of anxiety, depression, and substance use disorders in an urban general medicine practice. Arch Fam Med. 2000;9:876-883.
38. Stafford RS, Saglam D, Causino N, et al. Trends in adult visits to primary care physicians in the United States. Arch Fam Med. 1999;8:26-32.
39. Strothers HS 3rd, Rust G, Minor P, Fresh E, Druss B, Satcher D. Disparities in antidepressant treatment in Medicaid elderly diagnosed with depression. J Am Geriatr Soc. 2005;53:456-461. (Pubitemid 41623525)
40. Varkey AB, Manwell LB, Williams ES, et al. MEMO Investigators. Separate and unequal: clinics where minority and nonminority patients receive primary care. Arch Intern Med. 2009;169:243-250.
41. Bao Y, Alexopoulos GS, Casalino LP, et al. Collaborative depression care management and disparities in depression treatment and outcomes. Arch Gen Psychiatry. 2011;68:627-636.
42. Fiske A, Wetherell JL, Gatz M. Depression in older adults. Annu Rev Clin Psychol. 2009;5:363-389.
43. Lesser IM, Myers HF, Lin KM, et al. Ethnic differences in antidepressant response: a prospective multi-site clinical trial. Depress Anxiety. 2010;27:56-62.
44. Miranda J, Schoenbaum M, Sherbourne C, Duan N, Wells K. Effects of primary care depression treatment on minority patients' clinical status and employment. Arch Gen Psychiatry. 2004;61:827-834. (Pubitemid 39031122)
45. Roy-Byrne PP, Perera P, Pitts CD, Christi JA. Paroxetine response and tolerability among ethnic minority patients with mood or anxiety disorders: a pooled analysis. J Clin Psychiatry. 2005;66:1228-1233. (Pubitemid 41546501)
46. Areán PA, Gum AM, Tang L, Unützer J. Service use and outcomes among elderly persons with low incomes being treated for depression. Psychiatr Serv. 2007;58:1057-1064. (Pubitemid 47290863)
47. Areán PA, Ayalon L, Hunkeler E, et al. IMPACT Investigators. Improving depression care for older, minority patients in primary care. Med Care. 2005;43:381-390. (Pubitemid 40515627)
48. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet. 1995;345:1616-1619.
49. Warden D, Rush AJ, Wisniewski SR, et al. Income and attrition in the treatment of depression: a STAR*D report. Depress Anxiety. 2009;26:622-633.
50. Hayward RA, Kent DM, Vijan S, Hofer TP. Multivariable risk prediction can greatly enhance the statistical power of clinical trial subgroup analysis. BMC Med Res Methodol. 2006;6:18.
51. Rothwell PM, Mehta Z, Howard SC, Gutnikov SA, Warlow CP. From subgroups to individuals: general principles and the example of carotid endarterectomy. Lancet. 2005;365:256-265. (Pubitemid 40138020)
52. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI. Stratified randomization for clinical trials. J Clin Epidemiol. 1999;52:19-26. (Pubitemid 29064270)
53. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT. Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med. 2008;5:e45.
54. Cooper B. Economic recession and mental health: an overview. Neuropsychiatr. 2011;25:113-117.